2021
DOI: 10.1038/s41598-021-90554-3
|View full text |Cite|
|
Sign up to set email alerts
|

A potential role for somatostatin signaling in regulating retinal neurogenesis

Abstract: Neuropeptides have been reported to regulate progenitor proliferation and neurogenesis in the central nervous system. However, these studies have typically been conducted using pharmacological agents in ex vivo preparations, and in vivo evidence for their developmental function is generally lacking. Recent scRNA-Seq studies have identified multiple neuropeptides and their receptors as being selectively expressed in neurogenic progenitors of the embryonic mouse and human retina. This includes Sstr2, whose ligan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 51 publications
0
4
0
Order By: Relevance
“…In non-retinal tissues, Sstr2 functions as a somatostatin (Sst) receptor, that upon activation, functions to control of cell-cycle exit through accumulation of the downstream effector and cell-cycle inhibitor, p21 (Cdkn1a; Alderton et al, 2001 ). scRNA-seq of both Sstr2 knockout retinas or Sstr2 agonist-treated retinal explants indicate that Sstr2-activation may function to inhibit neurogenesis and specification of photoreceptors within the developing retina ( Weir et al, 2021 ). In this instance, scRNA-seq studies failed to detect large-scale transcriptional changes after either activation or inhibition of Sstr2 signaling, suggesting an inherent level of functional redundancy in the control of retinal neurogenesis.…”
Section: Phenotypingmentioning
confidence: 99%
“…In non-retinal tissues, Sstr2 functions as a somatostatin (Sst) receptor, that upon activation, functions to control of cell-cycle exit through accumulation of the downstream effector and cell-cycle inhibitor, p21 (Cdkn1a; Alderton et al, 2001 ). scRNA-seq of both Sstr2 knockout retinas or Sstr2 agonist-treated retinal explants indicate that Sstr2-activation may function to inhibit neurogenesis and specification of photoreceptors within the developing retina ( Weir et al, 2021 ). In this instance, scRNA-seq studies failed to detect large-scale transcriptional changes after either activation or inhibition of Sstr2 signaling, suggesting an inherent level of functional redundancy in the control of retinal neurogenesis.…”
Section: Phenotypingmentioning
confidence: 99%
“…Similarly, 11 known ligand-receptor interactions were identified between RPC and neurogenic cells, including multiple Notch-Delta pathway members (Supplementary Figure 2D) [23]. Interactions identified between RGC and neurogenic progenitors included Sst-Sstr2, which is known to play a role in photoreceptor generation and regulation of retinal neurogenesis [24] (Figure 4C, D).…”
Section: Resultsmentioning
confidence: 99%
“…In addition to the involvement of SST in the regulation of brain neurogenesis, a recent scRNA‐seq study demonstrated the potential role of SSTR2 signaling in retinal neurogenesis. The expression of SST and SSTR2 was found in immature retinal ganglion cells, and SSTR2‐activation modestly inhibited photoreceptor generation in retinal explants (Weir et al., 2021). Another recent study demonstrated that SST potentiates the regulation of the subcellular distribution and expression of neurotransmitters in the retinoic acid‐induced differentiation of human neuroblastoma cells (Singh et al., 2022).…”
Section: Discussionmentioning
confidence: 99%